Merck lung cancer drug Keytruda plus chemo gets FDA approval for NSCLC
Merck’s cancer immunotherapy Keytruda (pembrolizumab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA)
Continue readingCoverage of Global Pharma Industry News
Merck’s cancer immunotherapy Keytruda (pembrolizumab) in combination with chemotherapy has been approved by the US Food and Drug Administration (FDA)
Continue reading